Difference between revisions of "Team:Rheda Bielefeld"

Line 24: Line 24:
 
   -A:<a href="https://2018.igem.org/Team:Rheda_Bielefeld/Pollen"style=color:yellow;"> we collected pollen to work with</a>   
 
   -A:<a href="https://2018.igem.org/Team:Rheda_Bielefeld/Pollen"style=color:yellow;"> we collected pollen to work with</a>   
 
   -B: <a href"https://2018.igem.org/Team:Rheda_Bielefeld/Parts" style="color:yellow;">we tried to integrate genes for pectinases into the E.coli so that it can produce pectinases to  break the pollen</a>  
 
   -B: <a href"https://2018.igem.org/Team:Rheda_Bielefeld/Parts" style="color:yellow;">we tried to integrate genes for pectinases into the E.coli so that it can produce pectinases to  break the pollen</a>  
     -C. we extracted the pollens’ DNA link pollen
+
     -C: <a href="https://2018.igem.org/Team:Rheda_Bielefeld/Pollen" style="color:yellow;">we extracted the pollens’ DNA</a>
 
     -D: it is the idea of a test strip that identifies the pollen with our E.coli link </article><br><br>
 
     -D: it is the idea of a test strip that identifies the pollen with our E.coli link </article><br><br>
 
<h2> Abstract </h2>
 
<h2> Abstract </h2>

Revision as of 09:32, 17 October 2018






INTERPOLLEN






We are the Highschool team Rheda_Bielefeld from German and our projects’ name is INTERPOLLEN. With our project, we wanted to help as many people as possible and because in Germany there are many people who are allergic to pollen and need to take a lot of medicine because of their allergy, we wanted to develop a test strip with that each individual person can measure the local pollen dispersal. In the flow chart on the left, you can see our workflow. -A: we collected pollen to work with -B: we tried to integrate genes for pectinases into the E.coli so that it can produce pectinases to break the pollen -C: we extracted the pollens’ DNA -D: it is the idea of a test strip that identifies the pollen with our E.coli link


Abstract

A great percentage of Earth’s population is allergic to specific substances. Approximately 20 million people living in Germany are allergic to different plants, animals and much more, but close to half of them are allergic to pollen. We want to help these people suffering from an allergy to pollen by advising them which dose of medicine is necessary for every day.

Although there is already useful medicine, we are convinced that we can optimize the use of such medicine and reduce the exposure to unnecessary drugs which have negative side effects like lowering the personal performance capacity, becoming tired and many others.

Therefore we use a DNA-based method which uses pectinase and cellulase to open the pollen and isolates their DNA. This DNA will be used for a PCR with specific primers against the birch allergen "Bet". By hereby identifying pollen we aim to measure the current pollen exposure in the air.